That is necessary, due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be reliable. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (artificial intelligence). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're designed to do. This was a breakthrough almost nobody observed. But it's going to have profound implications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment chances in this area, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (self-driving cars). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back possibly substantially prior to going higher - black sea. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. However that's not the huge concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. first lady. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many great personal companies on the verge of hitting the public markets And I have actually been dealing with a new method for you to invest even before these business go public.
This opportunity has been building over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Journal. Regular Journal readers know that tech isn't our typical beat (angel investor). And when it comes to tech investing, we leave it to the professionals. Thankfully, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we understand (jeff brown biotech stock pick for 2020). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential growth and creating unbelievable chances for investors. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. biotech stocks jeff brown. However in spite of what lots of readers may believe, this is a pattern that's simply starting. Despite the fact that the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (self-driving cars). Losing 2 months of production and sales actually affects the number of 5G devices are sold in the fiscal year. When you consider all of that, offering 250 million units is exceptional. More importantly, the hold-ups brought on by the pandemic produced a lots of pent-up demand. Which need is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - first lady. And that's not my only 5G forecast When I have actually discussed 5G in the past, I've described its 3 various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage Three, 5G services begin to be offered (jeff brown biotech genome sequencing). That's when we start to see applications working on 5G networks. Believe of things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summer season. This starts something of a virtuous cycle: The majority of people don't really care about the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open a suite of unbelievable applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be massive. Stepping away from 5G, the next crucial innovation I predict in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For several years, CRISPR was mostly a specific niche innovation that wasn't well understood. And during that time, there were truly just three companies operating in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing unbelievable returns. This entire market is efficiently a greenfield chance.
There's space for numerous business to exist in this space. artificial intelligence. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can accurately predict the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is essential since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're created to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug therapies produced utilizing this technology. This was one of those developments that almost nobody noticed. But it's going to have extensive implications for treating illness. And, obviously, there will be a lot of investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly significantly prior to going greater. I've been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - jeff brown prediction for 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. jeff brown biotech stocks. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date as of February 2021, however we might not independently confirm this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to choose winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding perspective on the market. He's always on the hunt for brand-new chances, and he shares many of his finest choices in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an excellent credibility as a stock-picker, and he successfully predicted a few of the most significant financial events of the previous 20 years. Although he does not appear to launch his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best every time, however Jeff Brown's accurate forecasts have actually earned him legions of devoted fans. That states a lot about his ability. The Future Report is released by Brownstone Research study, a prominent monetary research publisher. Brownstone Research offers numerous research services with a variety of specializations - exponential tech investor.
The business is also connected with Bonner & Partners, another well-respected research publisher - united arab emirates. On its website, Brownstone says its objective is to supply retail investors with professional-grade research study: "For too long, the finest investment research has actually not been readily available to individual financiers. It has been generally reserved for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown biotech stocks. The objective of Brownstone Research is to make that type of exclusive research offered to any investors aiming to gain an edge in the marketplaces. The goal is simple to deliver unique and rewarding financial investment research found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise works as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. jeff brown top stock pick 2021. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown thinks S.A.V. brownstone research stock. could be "the most significant trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 cutting-edge technologies: synthetic intelligence and electric vehicles. Musk hopes the mix will assist him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the vehicle market's Holy Grail. As you understand, electrical lorries and self-driving cars and truck stocks have actually been huge this year, but the Wall Street machine has approved hype without much tangible result. Despite a drastic increase in competition over the previous couple of years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transport. Generally, this innovation would permit you to lease your automobile as an autonomous, self-driving taxi when you're not using it. You merely get out of the vehicle and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the earnings. It sounds crazy, however it could be closed than you think.